Cargando…
Complications and Toxicities Associated with Cancer Therapies in the Intensive Care Unit
Advances in the management of hematologic malignancies and solid tumors have given rise to diverse modalities to treat cancer other than cytotoxic chemotherapy, including targeted therapies, immunotherapies, and cellular therapies. Currently, there are over 175 FDA-approved antineoplastic agents in...
Autores principales: | Rivera, Melvin J., Do, Bryan, Bryan, Jeffrey C., Shigle, Terri Lynn, Patel, Rina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121489/ http://dx.doi.org/10.1007/978-3-319-74588-6_21 |
Ejemplares similares
-
Considerations for Medications Commonly Utilized in the Oncology Population in the Intensive Care Unit
por: Brown, Anne Rain Tanner, et al.
Publicado: (2019) -
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States
por: Mahmoudjafari, Zahra, et al.
Publicado: (2020) -
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant
por: Shigle, Terri Lynn, et al.
Publicado: (2020) -
Infectious complications associated with parenteral nutrition in intensive care unit and non-intensive care unit patients
por: Comerlato, Pedro Henrique, et al.
Publicado: (2020) -
Repair costs of reusable bronchoscopes in the intensive care unit
por: Kurman, Jonathan S., et al.
Publicado: (2022)